Materialise
Clinical trials sponsored by Materialise, explained in plain language.
Materialise
MTLS
NASDAQ
A 3D printing software and services company with medical applications.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Titanium implants under review: do they hold up over time? Results expected Nov 2026 (estimated)